BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 28687807)

  • 1. Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1.
    Jha SK; Rauniyar K; Karpanen T; Leppänen VM; Brouillard P; Vikkula M; Alitalo K; Jeltsch M
    Sci Rep; 2017 Jul; 7(1):4916. PubMed ID: 28687807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD.
    Bui HM; Enis D; Robciuc MR; Nurmi HJ; Cohen J; Chen M; Yang Y; Dhillon V; Johnson K; Zhang H; Kirkpatrick R; Traxler E; Anisimov A; Alitalo K; Kahn ML
    J Clin Invest; 2016 Jun; 126(6):2167-80. PubMed ID: 27159393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCBE1 enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activation.
    Jeltsch M; Jha SK; Tvorogov D; Anisimov A; Leppänen VM; Holopainen T; Kivelä R; Ortega S; Kärpanen T; Alitalo K
    Circulation; 2014 May; 129(19):1962-71. PubMed ID: 24552833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Dissection of the CCBE1 Protein: A Crucial Requirement for the Collagen Repeat Domain.
    Roukens MG; Peterson-Maduro J; Padberg Y; Jeltsch M; Leppänen VM; Bos FL; Alitalo K; Schulte-Merker S; Schulte D
    Circ Res; 2015 May; 116(10):1660-9. PubMed ID: 25814692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo.
    Bos FL; Caunt M; Peterson-Maduro J; Planas-Paz L; Kowalski J; Karpanen T; van Impel A; Tong R; Ernst JA; Korving J; van Es JH; Lammert E; Duckers HJ; Schulte-Merker S
    Circ Res; 2011 Aug; 109(5):486-91. PubMed ID: 21778431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
    Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
    J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The YAP-TEAD4 complex promotes tumor lymphangiogenesis by transcriptionally upregulating CCBE1 in colorectal cancer.
    Song J; Dang X; Shen X; Liu Y; Gu J; Peng X; Huang Z; Hong W; Cui L; Liu CY
    J Biol Chem; 2023 Apr; 299(4):103012. PubMed ID: 36781122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical cadherin FAT4 orchestrates lymphatic endothelial cell polarity in response to flow.
    Betterman KL; Sutton DL; Secker GA; Kazenwadel J; Oszmiana A; Lim L; Miura N; Sorokin L; Hogan BM; Kahn ML; McNeill H; Harvey NL
    J Clin Invest; 2020 Jun; 130(6):3315-3328. PubMed ID: 32182215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCBE1 promotes tumor lymphangiogenesis and is negatively regulated by TGFβ signaling in colorectal cancer.
    Song J; Chen W; Cui X; Huang Z; Wen D; Yang Y; Yu W; Cui L; Liu CY
    Theranostics; 2020; 10(5):2327-2341. PubMed ID: 32089745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of ADAMTS3 activity causes Hennekam lymphangiectasia-lymphedema syndrome 3.
    Brouillard P; Dupont L; Helaers R; Coulie R; Tiller GE; Peeden J; Colige A; Vikkula M
    Hum Mol Genet; 2017 Nov; 26(21):4095-4104. PubMed ID: 28985353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study.
    Visuri MT; Honkonen KM; Hartiala P; Tervala TV; Halonen PJ; Junkkari H; Knuutinen N; Ylä-Herttuala S; Alitalo KK; Saarikko AM
    Angiogenesis; 2015 Jul; 18(3):313-26. PubMed ID: 26018927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
    Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
    Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ccbe1 regulates Vegfc-mediated induction of Vegfr3 signaling during embryonic lymphangiogenesis.
    Le Guen L; Karpanen T; Schulte D; Harris NC; Koltowska K; Roukens G; Bower NI; van Impel A; Stacker SA; Achen MG; Schulte-Merker S; Hogan BM
    Development; 2014 Mar; 141(6):1239-49. PubMed ID: 24523457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential mRNA and tissue expression of lymphangiogenic growth factors (VEGF-C and -D) and their receptor (VEGFR-3) during tail regeneration in a gecko.
    Blacker HA; Orgeig S
    J Comp Physiol B; 2012 Jan; 182(1):109-26. PubMed ID: 21800152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Lymphangiogenic Factor CCBE1 Promotes Angiogenesis and Tumor Growth in Colorectal Cancer.
    Ding W; Tang W; Zhi J
    Curr Mol Med; 2022; 22(9):819-825. PubMed ID: 34819004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical E2fs control lymphangiogenesis through transcriptional regulation of Ccbe1 and Flt4.
    Weijts BG; van Impel A; Schulte-Merker S; de Bruin A
    PLoS One; 2013; 8(9):e73693. PubMed ID: 24069224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphangiogenesis in aortic valve stenosis--novel regulatory roles for valvular myofibroblasts and mast cells.
    Syväranta S; Helske S; Lappalainen J; Kupari M; Kovanen PT
    Atherosclerosis; 2012 Apr; 221(2):366-74. PubMed ID: 22281299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S1PR1 regulates the quiescence of lymphatic vessels by inhibiting laminar shear stress-dependent VEGF-C signaling.
    Geng X; Yanagida K; Akwii RG; Choi D; Chen L; Ho Y; Cha B; Mahamud MR; Berman de Ruiz K; Ichise H; Chen H; Wythe JD; Mikelis CM; Hla T; Srinivasan RS
    JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32544090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGFBP7 functions as a potential lymphangiogenesis inducer in non-small cell lung carcinoma.
    Zhao W; Wang J; Zhu B; Duan Y; Chen F; Nian W; Sun J; Zhang B; Tong Z; Chen Z
    Oncol Rep; 2016 Mar; 35(3):1483-92. PubMed ID: 26706909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular targeting of lymphatics for therapy.
    Stacker SA; Hughes RA; Achen MG
    Curr Pharm Des; 2004; 10(1):65-74. PubMed ID: 14754406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.